nirmatrelvir

Indications

• used in combination with ritonavir in Paxlovid to treat early outpatient Covid-19

Mechanism of action

• viral protease inhibitor
  • expected in vitro activity against all clinically significant SARS-CoV-2 variants as of December 22, 2021

More general terms

• antiviral agent

Component of

• Paxlovid (nirmatrelvir/ritonavir)
• nirmatrelvir/ritonavir